VanEck Biotech ETF (NASDAQ:BBH) Short Interest Up 427.3% in February

VanEck Biotech ETF (NASDAQ:BBH) was the recipient of a significant increase in short interest in February. As of February 28th, there was short interest totalling 11,600 shares, an increase of 427.3% from the February 13th total of 2,200 shares. Currently, 0.5% of the shares of the stock are sold short. Based on an average daily trading volume, of 10,500 shares, the short-interest ratio is currently 1.1 days.

Institutional Investors Weigh In On VanEck Biotech ETF

Large investors have recently made changes to their positions in the stock. Jane Street Group LLC grew its holdings in shares of VanEck Biotech ETF by 401.7% in the third quarter. Jane Street Group LLC now owns 8,348 shares of the company’s stock valued at $1,481,000 after purchasing an additional 6,684 shares during the period. SBI Securities Co. Ltd. acquired a new position in VanEck Biotech ETF in the 4th quarter valued at about $81,000. Flagship Harbor Advisors LLC boosted its holdings in VanEck Biotech ETF by 12.1% in the 4th quarter. Flagship Harbor Advisors LLC now owns 1,984 shares of the company’s stock valued at $311,000 after purchasing an additional 214 shares during the last quarter. Janney Montgomery Scott LLC purchased a new stake in shares of VanEck Biotech ETF in the 4th quarter valued at approximately $481,000. Finally, Kovitz Investment Group Partners LLC increased its holdings in shares of VanEck Biotech ETF by 4.6% during the 3rd quarter. Kovitz Investment Group Partners LLC now owns 3,186 shares of the company’s stock worth $565,000 after buying an additional 141 shares during the last quarter. 32.05% of the stock is currently owned by hedge funds and other institutional investors.

VanEck Biotech ETF Trading Up 0.1 %

BBH opened at $161.90 on Thursday. VanEck Biotech ETF has a twelve month low of $151.35 and a twelve month high of $183.64. The firm has a market capitalization of $395.04 million, a PE ratio of 30.97 and a beta of 0.85. The firm’s 50-day moving average price is $162.42 and its 200 day moving average price is $168.09.

VanEck Biotech ETF Announces Dividend

The business also recently announced a dividend, which was paid on Tuesday, December 24th. Stockholders of record on Monday, December 23rd were issued a dividend of $1.2517 per share. The ex-dividend date of this dividend was Monday, December 23rd.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.